These results may impact the management of patients with metabolic and cardiovascular diseases and highlight the need for further research on combination therapy to optimize outcomes
Many hypotheses for indirect metabolic antiepileptic effect of KD in the brain have been postulated as well
Serious reactions are much less common, and with the right provider, theyre easier to spot and address quickly
2x the servings than our competitors
Combination therapy was associated with a lower risk of primary composite outcomes of all-cause hospitalization, all-cause mortality, major adverse cardiovascular events (MACE), major adverse kidney events (MAKE), and major adverse liver outcomes (MALO) (hazard ratio [HR], 0.87
Most research protocols use one or the other based on study objectives, not both simultaneously